KK
EWTX icon

KLP Kapitalforvaltning’s Edgewise Therapeutics EWTX Stock Holding History

KLP Kapitalforvaltning’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$459K Hold
11,300
– – ﹤0.01% 1539
2026
Q1 		$356K Hold
11,300
– – ﹤0.01% 1583
2025
Q4 		$280K Buy
11,300
+700
+7% +$14.1K ﹤0.01% 1707
2025
Q3 		$172K Hold
10,600
– – ﹤0.01% 1876
2025
Q2 		$139K Buy
10,600
+3,800
+56% +$54.8K ﹤0.01% 1915
2025
Q1 		$150K Hold
6,800
– – ﹤0.01% 1873
2024
Q4 		$182K Buy
+6,800
New +$217K ﹤0.01% 1859

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

KLP Kapitalforvaltning's EWTX Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Edgewise Therapeutics (EWTX) position steady in Q2 2026 at 11,300 shares worth $459K. The position accounts for ﹤0.01% of the portfolio, ranked #1539.

KLP Kapitalforvaltning first reported a position in EWTX in Q4 2024 and has held it in 7 quarters since. 225 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • KLP Kapitalforvaltning held 11,300 shares of Edgewise Therapeutics worth $459K as of Q2 2026.
  • KLP Kapitalforvaltning left its Edgewise Therapeutics share count unchanged in Q2 2026.
  • Edgewise Therapeutics made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1539 holding.
  • KLP Kapitalforvaltning first reported a position in Edgewise Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 225 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.